Ministry of Health
Decree – Official Gazette n.300 of
Update of the tables containing the indication of narcotic and psychotropic substances, referred to in the Decree of the President of the Republic 9 October 1990, n.309 and subsequent amendments and additions
Insertion in Table I of the specific indication of MDMB-5Br-INACA, CUMIL-INACA, CUMIL-1Cl-CHSINACA.
THE MINISTER OF HEALTH
Having regard to Articles 2, 13 and 14 del decree del President della
Republic 9 October 1990, n. 309, e next amendments,
bearing the following: ‘Consolidated text of laws in matter di discipline degli
narcotics e substances psychotropic, di prevention, care e
rehabilitation of related drug addiction’, di followed
referred to as ‘Consolidated text’;
Having regard to the classification of the text unique relative alle substances
narcotic and psychotropic, subdivided in five tables named
‘Table I, II, III and IV and Table of medicinal products’;
Considering that in the aforementioned Tables I, II, III e IV find
collocation of substances with power addict e object di
abuse in descending order of potential of abuse e capacity di
induce dependence, in accordance with the criteria for the formation of
tables pursuant to art.14 of the Consolidated Law;
Having regard in particular to Article 14, paragraph 1, letter a) and letter d)
of the consolidated text, concerning the criteria for the formation of Table I;
Taking into account the note received on da part
of the Coordination Unit of the National Early Warning System
of the Department of Drug Policy of the Presidency del Council
dei ministers, concerning la signalling di new molecules:
MDMB-5Br-INACA, CUMIL-INACA, CUMIL-1Cl-CHSINACA, identified by la
first time in Europe, transmitted from the Observatory European on
Drugs and Drug Addiction (EMCDDA) at the Focal Point english in the
month of April 2022;
Taking into account that these substances have been identified for the
first time in Europe in the context of seizures carried out by the forces
of the order and which, in particular, la substance MDMB-5Br-INACA was
contained in a find seized by the Swiss police on 11
January 2022, la substance CUMIL-INACA was contained in artifacts
seized by the German police in November 2020 e from
police Hungarian in month di September 2021 e la substance
CUMIL-1Cl-CHSINACA was also present nello same find
seized by the Hungarian police on ;
Considered that le substances MDMB-5Br-INACA, CUMIL-INACA,
CUMIL-1Cl-CHSINACA are already sub control in Italy such as
structure analogues deriving da indazol-3-carboxamide included
nella Table I del text unique, without be name
specifically;
Deemed necessary, in relation to ai cited seizures, insert
in table I del text unique la specification indication of
substances MDMB-5Br-INACA, CUMIL-INACA, CUMIL-1Cl-CHSINACA, to
facilitate its prompt identification by law enforcement agencies;
Acquired the opinion of the Higher Institute of health, return with
note of , in favour of inclusion in the Table I
del text unique della specification indication of substances
MDMB-5Br-INACA, CUMIL-INACA, CUMIL-1Cl-CHSINACA;
Having obtained the opinion of the Board of Governors di health, expressed
at the sitting of , in favour of inclusion in
Table I of the consolidated text of the specific indication of substances
MDMB-5Br-INACA, CUMIL-INACA, CUMIL-1Cl-CHSINACA;
Considered, therefore, di dover proceed to update of
Table I of text unique, a protection della health publish, in
consideration of risks associated with the spread of new ones psychoactive substances
psychoactive on the market international, attributable a seizures
carried out in Europe and taking into account the need to facilitate le
related activities by law enforcement agencies;
Decree: Art.1
1. In Table I of the President’s decree della Republic 9
October 1990, n. 309, e next modifications, are Enter,
according to alphabetical order, the following substances:
CUMIL-1Cl-CHSINACA (common name);
1-(1-chlorocyclohexyl)sulfonyl-N-(1-methyl-1-phenyl-ethyl)indazol-3-ca
rboxamide (chemical name);
1-( ( (1-chlorocyclohexyl)sulfonyl)-N-(2-phenylpropan-2-yl)-1H-indazol
-3-carboxamide (other name);
CUMYL-1Cl-CHSINACA (other designation);
Cumil-ChloroCyclohexaneSulfonyl-IndazolCarboxAmide (other
name);
CUMIL-INACA (common name);
N-(2-phenylpropan-2-yl)-1H-indazol-3-carboxamide (naming
chemistry);
N-(1-methyl-1-phenyl-ethyl)-1H-indazol-3-carboxamide (other
name);
CUMYL-INACA (other name);
MDMB-5Br-INACA (common name);
Methyl 2-(5-bromo-1H-indazol-3-carboxamide)-3,3-dimethylbutanoate
(chemical name);
Methyl
2-[(5-bromo-1H-indazol-3-carbonyl)amino]-3,3-dimethylbutanoate (other
name);
MDMB-5-bromine-INACA (other designation);
The present decree entra in vigor the fifteenth day
following its publication in the Gazette Official
of the Italian Republic.
Rome,
The Minister: Schillaci
– Reproduction reserved and for personal use
Access to the site is restricted and reserved for healthcare professionals
You have reached the maximum number of visits
Source – https://www.univadis.it/viewarticle/inserimento-nella-tabella-i-della-specifica-indicazione-delle-sostanze-mdmb-5br-inacacumil-inaca-cumil-1cl-chsinaca